Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. (NASDAQ: TRUP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its business as a provider of medical insurance for cats and dogs. These SEC filings cover areas such as financial performance, risk factors, capital structure, governance, and material agreements that shape the company’s operations and its TRUP stock profile.
Key filings for Trupanion include annual reports on Form 10-K, which describe its subscription and other business segments, geographic reach, insurance entities, and risk considerations; and quarterly reports on Form 10-Q, which update investors on revenue from subscription and other business, enrolled pet counts, net income or loss, cash flows, and technology and development spending. Current reports on Form 8-K disclose material events, such as new credit agreements, earnings releases, and board appointments.
For example, Trupanion has used Form 8-K to report entering into a credit agreement with PNC Bank that provides term loan and revolving credit facilities secured by substantially all of the company’s and certain subsidiaries’ assets, and to announce the appointment of a new independent director to its board. Other 8-K filings reference the issuance of press releases detailing quarterly financial results.
Investors can also review Trupanion’s disclosures on non-GAAP financial measures, forward-looking statements, and risk factors, which are discussed in its periodic reports and referenced in earnings-related filings. These documents explain how the company views metrics such as adjusted EBITDA, net acquisition cost, and cash flow, and outline factors that could affect future performance, including claims trends, retention, regulatory constraints, and capital requirements.
On this page, Stock Titan presents Trupanion’s SEC filings alongside AI-powered summaries that highlight the main points of lengthy documents, such as 10-K and 10-Q reports. Users can quickly identify important information on segment performance, debt arrangements, and governance changes, while still having access to the full text of each filing for deeper review.
TRUPANION, INC. Chief Operating Officer John R. Gallagher reported equity compensation activity involving restricted stock units and common shares. On February 20, 2026, he received a grant of 16,609 RSUs that vest over time, beginning May 22, 2026.
On February 22, 2026, multiple RSU tranches vested and converted one-for-one into common stock through derivative exercises, increasing his direct common share holdings. On the same date, a total of 1,908 common shares were withheld at $27.16 per share to cover tax obligations, which the footnotes state does not represent a sale by Gallagher. After these transactions, he directly held 36,714 shares of common stock.
Trupanion, Inc. reports that Felix Holdings beneficially owns 4,296,538 shares of common stock, representing 9.89% of the class. The filing cites 43,430,169 shares outstanding as of 02/06/2026 per the company's Annual Report on Form 10-K filed 02/13/2026. The filing is signed by Gerhard Kotze on 02/24/2026.
Trupanion, Inc. reported the initial share ownership of its new Section 16 officer and Chief Legal Officer, Asher Bearman, effective February 4, 2026. Bearman beneficially owns 69,272 shares of common stock directly, a stock option for 4,397 shares at $17.97 per share, and several restricted stock unit awards that each convert into common stock on a one-for-one basis and vest over time.
Trupanion, Inc. files its annual report describing a fast-growing but still unprofitable pet insurance business focused on subscription coverage for cats and dogs in North America and parts of Europe. Total pets enrolled in its subscription segment reached 1,096,173 as of December 31, 2025, up from 31,200 in 2010, while subscription revenue grew from $19.1 million in 2010 to $989.3 million in 2025.
The company operates two segments: a higher-margin core subscription business and an "other" segment that underwrites policies for third parties, notably Pets Best, which it expects to decline over time. It targets returning about 71% of premiums as veterinary payments, funded by a data-driven pricing model and heavy investment in new pet acquisition, including $85.4 million of acquisition spend in 2025. Despite this scale, Trupanion reports an accumulated deficit of $206.5 million and highlights numerous risks, including sustained net losses, pricing and regulatory uncertainty, reliance on Territory Partners and strategic partners, technology and cyber risks, competitive pressure, and capital requirements for its multiple insurance entities in the U.S., Canada and Bermuda.
Trupanion reported strong fourth quarter and full-year 2025 results, highlighted by a return to solid profitability and double-digit growth. For 2025, total revenue reached $1,439.3 million, up 12% year over year, with subscription business revenue rising 16% to $989.3 million.
The company generated full-year net income of $19.4 million, or $0.45 per basic and diluted share, compared to a net loss of $9.6 million in 2024, including a $7.8 million realized gain from a preferred stock exchange. Adjusted EBITDA increased to $70.1 million from $46.1 million, while operating cash flow rose to $89.5 million and free cash flow to $75.4 million.
In the fourth quarter, revenue was $376.9 million, up 12%, with subscription revenue of $261.4 million, up 15%. Q4 net income was $5.6 million, or $0.13 per share, and adjusted EBITDA was $21.8 million. Subscription pets enrolled grew 5% to 1,096,173 at December 31, 2025, while total enrolled pets across all segments declined 2% to 1,647,565. Management noted achieving its 15% annual margin target and more than $150 million of discretionary profit in 2025.
Trupanion Chief Operating Officer John R. Gallagher reported selling 430 shares of Trupanion common stock on January 28, 2026 at a price of $31.67 per share. After this sale, he beneficially owned 31,861 shares of the company’s common stock.
The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan that Gallagher adopted on August 20, 2025 to pursue financial diversification. Under this plan, he had no discretion over the timing of the trade, which was executed automatically according to preset instructions.
Trupanion insider John Gallagher has filed a Form 144 notice to sell 430 shares of Trupanion common stock. The planned sale, through Morgan Stanley Smith Barney LLC on NASDAQ, has an aggregate market value of 13618.10 and is targeted for 01/28/2026.
The shares to be sold come from multiple restricted stock awards acquired from the issuer between 02/25/2022 and 02/25/2023, in blocks ranging from 7 to 132 shares. Trupanion had 43,198,164 common shares outstanding at the time listed.
Over the past three months, Gallagher has already sold Trupanion common stock, including 6,383 shares on 11/28/2025 for gross proceeds of 222282.86 and 430 shares on 12/29/2025 for 16146.50.
Trupanion director Murray B. Low exercised stock options to acquire additional shares. On January 9, 2026, he exercised a fully vested stock option for 23,213 shares of Trupanion common stock at an exercise price of $8.57 per share in a cash transaction. The corresponding derivative position (the option) was reduced to zero following the exercise. After the transaction, he directly owned 154,534 shares of Trupanion common stock. The company notes that no shares were sold as part of this transaction and that the option was exercised before its February 5, 2026 expiration.
Trupanion, Inc. (TRUP) Chief Operating Officer John R. Gallagher reported equity compensation activity involving restricted stock units and related tax withholding. On November 24, 2025, multiple restricted stock unit (RSU) awards converted into common stock, adding blocks of 3,328, 2,570, and 3,460 shares. The company withheld 1,309, 735, and 1,361 shares at a price of $35.4 per share to cover tax obligations, which the filing notes is not a sale by the executive. After these transactions, Gallagher directly owned 38,337 shares of Trupanion common stock. The RSUs stem from prior grants of 26,619, 20,559, and 13,838 units that vest over time, contingent on continued service.
Trupanion, Inc. (TRUP) director reports RSU conversions into common stock. On 11/24/2025, the reporting person acquired 312 shares of common stock and later 6,250 shares, following the exercise (code M) of restricted stock units (RSUs). After these transactions, the person directly beneficially owned 27,527 shares after the first acquisition and 33,777 shares after the second.
The transactions relate to RSU awards granted on February 27, 2024. One grant of 5,000 RSUs vests 1/4 of the shares on February 22, 2025, then 1/16 quarterly, while a separate grant of 50,000 RSUs vests 1/8 on May 22, 2024, then 1/8 quarterly, in each case subject to continued service. Following the reported activity, 2,813 RSUs remain from the smaller grant and 6,250 RSUs remain from the larger grant, each convertible into common stock on a one-for-one basis.